Literature DB >> 14566232

Gender-related differences in morbidity and mortality during combined valve and coronary surgery.

Mohamed F Ibrahim1, Domenico Paparella, Joan Ivanov, Michael R Buchanan, Stephanie J Brister.   

Abstract

BACKGROUND: Gender-related differences in morbidity and mortality are well described for coronary artery bypass grafting but are not well understood for combined valve and bypass surgery.
METHODS: We reviewed retrospectively the morbidity and mortality of 1570 consecutive patients who underwent combined valve and bypass procedures at the Toronto General Hospital between January 1990 and October 2000.
RESULTS: There were 1073 men (68%) and 497 women (32%). The mean ages (+/- 1 SD) of women and men were 69 +/- 9 and 68 +/- 9 years, respectively (P =.02). Of the 1570 total patients, 973 patients (62%) underwent aortic valve and coronary bypass surgery, 481 patients (31%) had mitral valve and coronary bypass operations, and 116 (7%) patients had double or triple valve and coronary bypass operations. Preoperative hypertension (P =.002), diabetes (P =.001), and atrial fibrillation (P =.001) were seen more frequently in women. Body surface area was significantly lower in women (P =.0001). At presentation, more women were in congestive heart failure (69% vs 58%, P =.001) and in New York Heart Association functional class III or IV (25% vs 19%, P =.001). Although there was no difference in the number of women with three or more diseased vessels (32% vs 38%), only 35% of women received three or more grafts compared with 44% of men (P =.001). The use of left internal thoracic grafts, although uncommon in the whole study population (36%), was less common in women than in men (26% vs 41%, P =.001). Multivariable logistic analyses for morbidity and mortality showed female gender to be an independent risk factor. Mitral valve replacement, age, left ventricular dysfunction, New York Heart Association classes III and IV, and association of tricuspid valve disease, diabetes, peripheral vascular disease, and preoperative renal failure were found to be independent risk factors for mortality.
CONCLUSION: Female gender is an independent risk factor for combined morbidity and mortality during and after combined valve and coronary bypass surgery. As with isolated coronary artery bypass grafting, women undergoing combined procedures have more premorbid conditions, are more often in heart failure, had an equal incidence of triple vessel disease but received fewer grafts than men, and, therefore, were more frequently incompletely revascularized.

Entities:  

Mesh:

Year:  2003        PMID: 14566232     DOI: 10.1016/s0022-5223(03)00355-6

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Sex Differences in the Utilization and Outcomes of Surgical Aortic Valve Replacement for Severe Aortic Stenosis.

Authors:  Zakeih Chaker; Vinay Badhwar; Fahad Alqahtani; Sami Aljohani; Chad J Zack; David R Holmes; Charanjit S Rihal; Mohamad Alkhouli
Journal:  J Am Heart Assoc       Date:  2017-09-21       Impact factor: 5.501

2.  Statin therapy improves outcomes after valvular heart surgery.

Authors:  Lynn M Fedoruk; Hongkun Wang; Mark R Conaway; Irving L Kron; Karen C Johnston
Journal:  Ann Thorac Surg       Date:  2008-05       Impact factor: 4.330

3.  How much does a heart valve implantation cost and what are the health care costs afterwards?

Authors:  Simone A Huygens; Lucas M A Goossens; Judith A van Erkelens; Johanna J M Takkenberg; Maureen P M H Rutten-van Mölken
Journal:  Open Heart       Date:  2018-02-14

4.  Impact of type 2 diabetes mellitus in the utilization and in-hospital outcomes of surgical aortic valve replacement in Spain (2001-2015).

Authors:  Ana López-de-Andrés; Napoleon Perez-Farinos; Javier de Miguel-Díez; Valentín Hernández-Barrera; Manuel Méndez-Bailón; José M de Miguel-Yanes; Rodrigo Jiménez-García
Journal:  Cardiovasc Diabetol       Date:  2018-10-16       Impact factor: 9.951

5.  Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement.

Authors:  Anvesha Singh; Tarique Al Musa; Thomas A Treibel; Vassiliou S Vassiliou; Gabriella Captur; Calvin Chin; Laura E Dobson; Silvia Pica; Margaret Loudon; Tamir Malley; Marzia Rigolli; James Robert John Foley; Petra Bijsterveld; Graham R Law; Marc Richard Dweck; Saul G Myerson; Sanjay K Prasad; James C Moon; John P Greenwood; Gerry P McCann
Journal:  Heart       Date:  2019-08-29       Impact factor: 5.994

6.  National Trends in Utilization and In-Hospital Outcomes of Surgical Aortic Valve Replacements in Spain, 2001-2015.

Authors:  Rodrigo Jiménez-García; Napoleón Perez-Farinos; Javier de Miguel-Díez; Valentín Hernández-Barrera; Manuel Méndez-Bailón; Isabel Jimenez-Trujillo; José M de Miguel-Yanes; Ana López-de-Andrés
Journal:  Braz J Cardiovasc Surg       Date:  2020-02-01

Review 7.  Gender differences in the susceptibility of hospital-acquired acute kidney injury: more questions than answers.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2020-07-13       Impact factor: 2.370

8.  Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes.

Authors:  Eike Tigges; Daniel Kalbacher; Christina Thomas; Sebastian Appelbaum; Florian Deuschl; Niklas Schofer; Michael Schlüter; Lenard Conradi; Johannes Schirmer; Hendrik Treede; Hermann Reichenspurner; Stefan Blankenberg; Ulrich Schäfer; Edith Lubos
Journal:  Biomed Res Int       Date:  2016-03-02       Impact factor: 3.411

Review 9.  Contemporary outcomes after surgical aortic valve replacement with bioprostheses and allografts: a systematic review and meta-analysis.

Authors:  Simone A Huygens; Mostafa M Mokhles; Milad Hanif; Jos A Bekkers; Ad J J C Bogers; Maureen P M H Rutten-van Mölken; Johanna J M Takkenberg
Journal:  Eur J Cardiothorac Surg       Date:  2016-03-29       Impact factor: 4.191

10.  Sex-stratified analysis of national trends and outcomes in isolated tricuspid valve surgery.

Authors:  Pranav Chandrashekar; Erin Amanda Fender; Chad J Zack; Yogesh N V Reddy; Courtney E Bennett; Megha Prasad; Mohammed A Al-Hijji; John M Stulak; Virginia M Miller
Journal:  Open Heart       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.